Anti-CIA2A/ CIAO2A/ FAM96A functional antibody
Anti-CIA2A/ CIAO2A/ FAM96A functional antibody for cell culture, ELISA & in-vivo assay
Go to CIAO2A/CIAO2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1575-Ab-1/ GM-Tg-hg-SE1575-Ab-2 | Anti-Human CIAO2A monoclonal antibody | Human |
GM-Tg-rg-SE1575-Ab-1/ GM-Tg-rg-SE1575-Ab-2 | Anti-Rat CIAO2A monoclonal antibody | Rat |
GM-Tg-mg-SE1575-Ab-1/ GM-Tg-mg-SE1575-Ab-2 | Anti-Mouse CIAO2A monoclonal antibody | Mouse |
GM-Tg-cynog-SE1575-Ab-1/ GM-Tg-cynog-SE1575-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CIAO2A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1575-Ab-1/ GM-Tg-felg-SE1575-Ab-2 | Anti-Feline CIAO2A monoclonal antibody | Feline |
GM-Tg-cang-SE1575-Ab-1/ GM-Tg-cang-SE1575-Ab-2 | Anti-Canine CIAO2A monoclonal antibody | Canine |
GM-Tg-bovg-SE1575-Ab-1/ GM-Tg-bovg-SE1575-Ab-2 | Anti-Bovine CIAO2A monoclonal antibody | Bovine |
GM-Tg-equg-SE1575-Ab-1/ GM-Tg-equg-SE1575-Ab-2 | Anti-Equine CIAO2A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1575-Ab-1/ GM-Tg-hg-SE1575-Ab-2; GM-Tg-rg-SE1575-Ab-1/ GM-Tg-rg-SE1575-Ab-2; GM-Tg-mg-SE1575-Ab-1/ GM-Tg-mg-SE1575-Ab-2; GM-Tg-cynog-SE1575-Ab-1/ GM-Tg-cynog-SE1575-Ab-2; GM-Tg-felg-SE1575-Ab-1/ GM-Tg-felg-SE1575-Ab-2; GM-Tg-cang-SE1575-Ab-1/ GM-Tg-cang-SE1575-Ab-2; GM-Tg-bovg-SE1575-Ab-1/ GM-Tg-bovg-SE1575-Ab-2; GM-Tg-equg-SE1575-Ab-1/ GM-Tg-equg-SE1575-Ab-2 |
Products Name | Anti-CIAO2A monoclonal antibody |
Format | mab |
Target Name | CIAO2A |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-CIAO2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1575-Ag-1 | Recombinant multi-species CIA2A/ CIAO2A/ FAM96A protein |
ORF Viral Vector | pGMLP003413 | human FAM96A Lentivirus plasmid |
ORF Viral Vector | vGMLP003413 | human FAM96A Lentivirus particle |
Target information
Target ID | GM-SE1575 |
Target Name | CIAO2A |
Gene ID | 84191,68250,300797,712029,478335,101089269,512871,100053881 |
Gene Symbol and Synonyms | 5730536A07Rik,CIA2A,CIAO2A,FAM96A,RGD1307481 |
Uniprot Accession | Q9H5X1,Q3T0U7 |
Uniprot Entry Name | CIA2A_HUMAN,CIA2A_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000166797 |
Target Classification | N/A |
The target: CIAO2A, gene name: CIAO2A, also named as CIA2A, FAM96A. Predicted to enable metal ion binding activity. Involved in iron-sulfur cluster assembly and protein maturation by iron-sulfur cluster transfer. Located in cytosol and nucleoplasm. Part of CIA complex. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.